Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease

被引：8
|
作者：
Sinning, Christoph [1 ]
Schnabel, Renate B. [1 ]
Zeller, Tanja [1 ]
Seiffert, Moritz [1 ]
Rupprecht, Hans J. [2 ]
Lackner, Karl J. [3 ]
Blankenberg, Stefan [1 ]
Bickel, Christoph [4 ]
Westermann, Dirk [1 ]
机构：
[1] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany
[2] GPR Klinikum Russelsheim, Dept Internal Med 2, Hamburg, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Clin Chem & Lab Med, Mainz, Germany
[4] Fed Armed Forces Cent Hosp, Dept Internal Med, Koblenz, Germany
来源：
BIOMARKERS IN MEDICINE | 2016年 / 10卷 / 01期
关键词：
angiogenesis; coronary artery disease; placental growth factor; soluble fms-like tyrosine kinase-1; vascular endothelial growth factor; ACUTE MYOCARDIAL-INFARCTION; CHRONIC HEART-FAILURE; ADVERSE OUTCOMES; ANGIOGENESIS; EXPRESSION; ATHEROSCLEROSIS; RISK; RECEPTOR; REVASCULARIZATION; IMPROVEMENT;
D O I：
10.2217/bmm.15.111
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Background: Intention of the study is to assess the cardiovascular mortality of patients with coronary artery disease (CAD) with the biomarkers of angiogenesis PlGF and its endogenous inhibitor sFlt-1. Methods: The cohort included n = 1848 patients with CAD and 282 subjects without CAD. In 85 patients cardiovascular mortality, as combination of fatal myocardial infarction or any cardiac death, during a median follow-up duration of 3.9 years was reported. Results: In Kaplan-Meier curve analysis PlGF in rising thirds was not predictive regarding outcome (p = 0.54), the same was shown for sFlt-1 (p = 0.44). Cox regression for the fully adjusted model provided a hazard ratio (HR) of 0.8 (p = 0.18) for PlGF and for sFlt-1 a HR = 1.0 (p = 0.8). Conclusion: Our results point out that these biomarkers reflecting angiogenesis might not be suited to establish prognosis in CAD.
引用
收藏
页码：95 / 106
页数：12
相关论文
共 50 条
  • [1] An Elevated Ratio of Placental Growth Factor to Soluble Fms-like Tyrosine Kinase-1 Predicts Adverse Outcomes in Patients with Stable Coronary Artery Disease
    Matsumoto, Takaki
    Uemura, Shiro
    Takeda, Yukiji
    Matsui, Masaru
    Okada, Sadanori
    Nishida, Taku
    Soeda, Tsunenari
    Okayama, Satoshi
    Somekawa, Satoshi
    Ishigami, Ken-ichi
    Onoue, Kenji
    Kawata, Hiroyuki
    Kawakami, Rika
    Horii, Manabu
    Saito, Yoshihiko
    INTERNAL MEDICINE, 2013, 52 (10) : 1019 - 1027
  • [2] Elevated Ratio of Placental Growth Factor to Soluble Fms-Like Tyrosine Kinase-1 Predicts an Adverse Outcome in Patients with Chronic Coronary Artery Disease
    Matsumoto, Takaki
    Uemura, Shiro
    Matsui, Masaru
    Senoo, Ayako
    Takeda, Yukiji
    Onoue, Kenji
    Horii, Manabu
    Saito, Yoshihiko
    CIRCULATION, 2011, 124 (21)
  • [3] Vascular Endothelial Growth Factor, Soluble Fms-Like Tyrosine Kinase 1, and the Severity of Coronary Artery Disease
    Kim, Soo-Young
    Lee, Sang-Hak
    Park, Sungha
    Kang, Seok-Min
    Chung, Namsik
    Shim, Won-Heum
    Cho, Seung-Yun
    Jee, Sun Ha
    Manabe, Ichiro
    Jang, Yangsoo
    ANGIOLOGY, 2011, 62 (02) : 176 - 183
  • [4] Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia
    Boulanger, H.
    Drouin, D.
    Largilliere, C.
    Lefevre, G.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (08) : 695 - 697
  • [5] Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase-1 and Placental Growth Factor in HIV-infected Preeclampsia
    Mlambo, Zinhle P. P.
    Khaliq, Olive P. P.
    Moodley, Jagidesa
    Naicker, Thajasvarie
    CURRENT HYPERTENSION REVIEWS, 2023, 19 (01) : 27 - 33
  • [6] Placental Growth Factor and Soluble, Fms-Like Tyrosine Kinase-1 in Preeclampsia: A Case-Cohort (PEARL) Study
    Fillion, Alexandre
    Guerby, Paul
    Lachance, Caroline
    Comeau, Marie-Pier
    Bussieres, Marie-Claude
    Doucet-Gingras, Felicia-Allysson
    Zerounian, Sophie
    Demers, Suzanne
    Laforest, Genevieve
    Menzies, Didier
    Bujold, Emmanuel
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (10) : 1235 - 1242
  • [7] Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction
    Herraiz, Ignacio
    Droege, Lisa Antonia
    Gomez-Montes, Enery
    Henrich, Wolfgang
    Galindo, Alberto
    Verlohren, Stefan
    OBSTETRICS AND GYNECOLOGY, 2014, 124 (02): : 265 - 273
  • [8] In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies
    Holme, Ane M.
    Roland, Marie C. P.
    Henriksen, Tore
    Michelsen, Trond M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (06)
  • [9] Lipoproteins and Exosomes as Novel Carriers of Soluble Fms-Like Tyrosine Kinase-1 and Placental Growth Factor During Pregnancy
    Tan, Lunbo
    van Heugten, Martijn H.
    Kluivers, Ans C. M.
    van der Zee, Leonie van Vark
    Mulder, Monique T.
    Lu, Xifeng
    Danser, A. H. Jan
    Verdonk, Koen
    HYPERTENSION, 2024, 81 (10) : e132 - e134
  • [10] DISEASE ACTIVITY IN PREGNANT WOMEN WITH RHEUMATOID ARTHRITIS: IMPACT ON THE SOLUBLE FMS-LIKE TYROSINE KINASE-1 TO PLACENTAL GROWTH FACTOR RATIO
    Smeele, H. T.
    Neuman, R. I.
    Danser, A. H. J.
    Dolhain, R.
    Visser, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 505 - 505
12345